CompuMed CMPD · USD

Market value

$6.2m

Last close × shares

Volume

200

Shares, 9 Nov 2026

Its shares trade under the ticker CMPD. It has been listed since 28 May 1987. In the fiscal year to 30 September 2025, it reported revenue of $7.5m and a net loss of $64,227. At that date it held total assets of $5.0m and shareholders' equity of $3.1m.

CompuMed, Inc. engages in the provision of enterprise telemedicine solutions. The company is headquartered in Los Angeles, California. The firm's telecardiology and teleradiology offerings provide direct access to the United States Board-Certified specialists through cloud-based technology and integrated medical devices. Its solutions primarily support the diagnosis and treatment of various diseases, particularly cardiovascular disease and osteoporosis. The firm operates a network for remote electronic processing of electrocardiograms (ECGs), echocardiograms (Echos), ultrasound studies and X-rays. The firm provides ECG equipment and cardiology services to its clients. Its ECG devices include GE MAC 1200, Mortara ELI 100 and Schiller AT-102. Its ultrasound devices include GE Vscan, GE Vivid e and GE Vivid i. The company has created an electronic telemedicine infrastructure to link clinical diagnostic equipment data collected at the patient's point of care with specialists through its call center. The company also provides access to specialists for consultations.

Figures and description from our data supplier, not checked against the company's own report.

More about CompuMed →

We have not reported on CompuMed yet.

Leaves out fees, taxes and financing.

Chart

TradingView

Close and company data

Our data supplier

News

Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.